FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 9836811 · Received March 16, 2020

Report

Report Number
1416980-2020-01430
Event Type
Malfunction
Date Received
March 16, 2020
Date of Event
February 14, 2020
Report Date
April 9, 2020
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
MEB
UDI-DI
00085412081441
PMA / PMN Number
K071222
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS ADDED: PMA/510K # CORRECTION: K071222 (PREVIOUSLY NA). THE LOT WAS MANUFACTURED FROM JULY 23, 2019 - JULY 24, 2019. ONE (1) ACTUAL SAMPLE WAS RECEIVED FOR EVALUATION. VISUAL INSPECTION WAS PERFORMED AND FOUND THE BLADDER HAS BEEN RUPTURED. THE RUPTURED BLADDER WAS MICROSCOPICALLY EXAMINED AND THERE WERE NO SIGNS OF ABNORMALITY THAT MAY HAVE POTENTIALLY CAUSED THE RUPTURE PROBLEM. THE REPORTED CONDITION OF UNSPECIFIED DAMAGE WAS CONFIRMED TO BE A RUPTURED BLADDER. THE CAUSE OF THE RUPTURED BLADDER COULD NOT BE DETERMINED. THE REMAINING DEVICE WAS NOT RECEIVED FOR EVALUATION; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(6). THE DEVICE WAS RECEIVED AND IS CURRENTLY AWAITING EVALUATION. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE BLADDER OF TWO (2) SMALL VOLUME INFUSORS WERE OBSERVED TO HAVE UNSPECIFIED DAMAGE. THESE ISSUES WERE OBSERVED DURING SETUP/PREPARATION PRIOR TO PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
300669 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE CORPORATION NA 19G029 00085412081441

Patients

Seq Age Sex Outcome Treatment
1